ArticleProbiotics and antimicrobial proteins2026
Emerging Synbiotics Consisting of Catechin and Probiotic Bacteria: Exploring Aggregation, Adhesion, Antioxidant, and Anticancer Effects.
Article in Probiotics and antimicrobial proteins, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Effect of tea catechins and lactic acid onBioscience of microbiota, food and health · 2026Article
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Probiotic bacteria are microorganisms that confer health benefits on the host, when administered in adequate amounts. Catechin, naturally found in nature and human diet, has strong antioxidant, antibacterial, and anticancer potentials. Phenolic compounds and probiotic bacteria are found together in gastrointestinal tract (GIT), and their potential synbiotic interactions are not fully understood. The present study aims to investigate the probiotic properties effects of catechin on (bacterial growth, auto-aggregation, co-aggregation) on well-known probiotic bacteria Lactobacillus acidophilus LA-5 (LA-5) and Lacticaseibacillus rhamnosus GG (LGG), and in vitro cytotoxic effects of the synbiotic combination of catechin and probiotic bacteria on colon cancer cells Caco-2. Results show that catechin contributed to bacterial growth of LA-5, auto-aggregation of LA-5, co-aggregation of LA-5 with Staphylococcus aureus. Catechin increased the adhesion potential of LA-5 and LGG by 6% and 5%, respectively. In DPPH scavenging activity, LGG grown with catechin exerted 30% more antioxidant potential compared the LGG. Moreover, LA-5 grown in the presence of catechin led to higher cell death of Caco-2 when compared to control while it did not influence the genotoxicity property of LA-5. However, catechin did not promote the cytotoxicity and genotoxicity properties of LGG. In conclusion, catechin enhanced many physiological properties of probiotic bacteria and thus, synbiotic relationship of catechin and probiotics may offer novel insights into the prevention/treatment of colon cancer.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.